PM vs MO vs PG
161 measures in 16 categories, one definition each, computed from filings and market data.
PM76.7
Philip Morris International Inc.
Consumer Defensive · Tobacco
$205.20 +2.51%$319.8B mkt cap
Score DNA
PG64.1
The Procter & Gamble Company
Consumer Defensive · Household & Personal Products
$159.31 +1.45%$370.0B mkt cap
Score DNA
Price, rebased to 100 three years ago
PM MO PG · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry (these stocks sit in different industries). n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | PM | MO | PG |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 1 | 0 |
| Insider $ bought, 180d | — | $0.10M | — |
| Congress purchases, 180d | 3 | 1 | 16 |
| Last Congress purchase | 2026-06-02 | 2026-09-04 | 2026-09-25 |
| 13F net change in holders | +68 | +77 | +20 |
| ETFs adding shares, 30d | 1,130 | 944 | 1,512 |
| ETFs trimming, 30d | 823 | 708 | 1,258 |
| Net ETF funds, 30d | +307 | +236 | +254 |
Valuation
16 measures| Measure | PM | MO | PG |
|---|---|---|---|
| P/E (TTM) | 29.4x | 15.7x | 23.1x
55th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 2.85 | 2.07 | 5.99
100th
|
| Price / sales | 7.5x | 5.7x | 4.3x
100th
|
| Price / book | — | — | 6.8x
79th
|
| Price / tangible book | — | — | — |
| Price / free cash flow | 25.1x | 15.1x | 23.3x
75th
|
| Price / operating cash flow | 22.4x | 14.5x | 18.2x
81st
|
| Enterprise value | $362.9B | $147.6B | $395.1B
100th
|
| EV / sales | 8.5x | 6.7x | 4.5x
100th
|
| EV / EBITDA | 19.4x | 12.6x | 16.2x
44th
|
| EV / EBIT | 21.8x | 12.9x | 18.6x
43rd
|
| EV / free cash flow | 28.5x | 17.8x | 24.8x
69th
|
| Earnings yield | 3.4% | 6.4% | 4.3%
68th
|
| FCF yield | 4.0% | 6.6% | 4.3%
37th
|
| Operating cash flow yield | 4.5% | 6.9% | 5.5%
32nd
|
| Graham number (per share) | — | — | $57.80
91st
|
Profitability (TTM)
12 measures| Measure | PM | MO | PG |
|---|---|---|---|
| Gross margin | 67.5% | 69.9% | 50.2%
53rd
|
| EBITDA margin | 44.0% | 53.3% | 28.1%
100th
|
| Operating margin | 37.7% | 50.2% | 22.7%
95th
|
| EBIT margin | 39.2% | 52.4% | 24.4%
100th
|
| Net margin | 25.6% | 36.4% | 18.4%
100th
|
| NOPAT margin | 30.0% | 38.6% | 18.0%
95th
|
| FCF margin | 29.9% | 37.9% | 18.3%
95th
|
| Operating cash flow margin | 33.5% | 39.5% | 23.4%
100th
|
| R&D / revenue | 0.0% | 0.0% | 0.0%
0th
|
| SG&A / revenue | 29.1% | 11.0% | 27.5%
26th
|
| Stock comp / revenue | 0.0% | 0.0% | 0.6%
33rd
|
| Effective tax rate | 20.6% | 23.2% | 20.8%
5th
|
Returns on capital
11 measures| Measure | PM | MO | PG |
|---|---|---|---|
| ROE (on average equity) | — | — | 30.2%
84th
|
| ROA | 15.9% | 24.3% | 12.7%
100th
|
| ROIC | 36.9% | 43.2% | 19.7%
68th
|
| ROCE | 39.9% | 44.8% | 24.2%
95th
|
| Return on tangible assets | 24.4% | 34.9% | 16.9%
89th
|
| Cash ROIC (OCF / invested capital) | 41.3% | 44.2% | 25.6%
76th
|
| Gross profitability (GP / assets) | 42.1% | 44.3% | 34.5%
47th
|
| ROIC, 3-yr average | 36.2% | 37.6% | 17.4%
82nd
|
| ROIC, 5-yr average | — | — | 20.6%
93rd
|
| ROE, 5-yr average | — | — | 30.6%
88th
|
| Incremental ROIC | 602.2% | 381.1% | 160.6%
95th
|
Growth
17 measures| Measure | PM | MO | PG |
|---|---|---|---|
| Revenue growth (TTM YoY) | 9.1% | 8.0% | 3.3%
68th
|
| Revenue growth (QoQ) | 10.3% | -1.3% | -0.2%
21st
|
| Revenue CAGR, 3 yr | 8.7% | 1.9% | 2.0%
56th
|
| Revenue CAGR, 5 yr | 7.2% | 0.6% | 2.7%
53rd
|
| Gross profit CAGR, 3 yr | 11.2% | 1.1% | 3.6%
39th
|
| Operating income CAGR, 3 yr | 12.8% | -1.8% | 2.9%
33rd
|
| Net income growth (TTM YoY) | 32.4% | -9.3% | 0.5%
50th
|
| Net income CAGR, 3 yr | 10.6% | 5.4% | 3.1%
30th
|
| EPS growth (TTM YoY) | 31.9% | -8.6% | 1.8%
50th
|
| EPS CAGR, 3 yr | 10.3% | 7.6% | 3.8%
30th
|
| EPS CAGR, 5 yr | 4.1% | 14.2% | 3.6%
78th
|
| FCF growth (TTM YoY) | 41.5% | -4.9% | 13.3%
15th
|
| FCF CAGR, 3 yr | 19.7% | -1.1% | 4.9%
46th
|
| Operating cash flow CAGR, 3 yr | 18.2% | -0.6% | 6.4%
57th
|
| Book value CAGR, 3 yr | — | — | 5.9%
65th
|
| Dividend CAGR, 3 yr | 2.3% | 1.9% | 2.0%
92nd
|
| Sustainable growth rate | — | — | 10.9%
73rd
|
Margin history & stability
7 measures| Measure | PM | MO | PG |
|---|---|---|---|
| Gross margin, 3-yr average | 65.8% | 69.6% | 50.9%
53rd
|
| Operating margin, 3-yr average | 36.6% | 53.2% | 23.0%
100th
|
| Net margin, 3-yr average | 23.6% | 43.3% | 18.4%
100th
|
| FCF margin, 3-yr average | 26.9% | 41.5% | 18.7%
100th
|
| Revenue stability (0-1) | 0.97 | 0.01 | 0.95
79th
|
| Earnings stability (0-1) | 0.19 | 0.52 | 0.85
89th
|
| Margin stability (0-1) | 0.97 | 0.97 | 0.97
74th
|
Liquidity (latest quarter)
7 measures| Measure | PM | MO | PG |
|---|---|---|---|
| Cash & short-term investments | $6.0B | $2.4B | $9.9B
100th
|
| Net cash (− = net debt) | −$43.1B | −$22.2B | −$25.1B
0th
|
| Working capital | −$536.0M | −$4.3B | −$12.5B
0th
|
| Current ratio | 0.98 | 0.44 | 0.68
5th
|
| Quick ratio | 0.55 | 0.30 | 0.47
11th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.23 | 0.30 | 0.26
47th
|
| Defensive interval (days) | 359 days | 258 days | 244 days
42nd
|
Leverage & solvency (latest quarter)
13 measures| Measure | PM | MO | PG |
|---|---|---|---|
| Total debt | $49.1B | $24.6B | $35.0B
100th
|
| Debt / equity | — | — | 0.64
32nd
|
| Net debt / equity | — | — | 0.46
26th
|
| Debt / assets | 71.9% | 73.6% | 27.7%
32nd
|
| Debt / capital | — | — | 39.2%
32nd
|
| Debt / EBITDA | 2.62 | 2.11 | 1.43
6th
|
| Net debt / EBITDA | 2.30 | 1.90 | 1.03
6th
|
| Interest coverage (EBIT / interest) | 10.8x | 10.5x | 24.2x
94th
|
| Cash interest coverage | 9.2x | 7.9x | 23.2x
89th
|
| Debt payback (years of OCF) | 3.4 yrs | 2.8 yrs | 1.7 yrs
12th
|
| Liabilities / assets | 109.8% | 107.8% | 57.1%
42nd
|
| IS credit model rating | B- | A | AA |
| Implied credit spread (bps) | 900 | 150 | 80
5th
|
Efficiency
11 measures| Measure | PM | MO | PG |
|---|---|---|---|
| Asset turnover | 0.62 | 0.67 | 0.69
26th
|
| Fixed asset turnover | 5.12 | 12.45 | 3.43
17th
|
| Inventory turnover | 1.2 | 6.9 | 5.5
68th
|
| Receivables turnover | 8.4 | 80.0 | 14.2
79th
|
| Days sales outstanding | 44 days | 5 days | 26 days
21st
|
| Days inventory outstanding | 293 days | 53 days | 66 days
32nd
|
| Days payables outstanding | 103 days | 32 days | 133 days
84th
|
| Cash conversion cycle (days) | 233 days | 26 days | −41 days
5th
|
| Capex / revenue | 3.6% | 1.5% | 5.1%
100th
|
| Capex / depreciation | 0.75 | 1.66 | 1.40
100th
|
| Operating expense ratio | 28.0% | 12.4% | 29.9%
28th
|
Cash flow & earnings quality
7 measures| Measure | PM | MO | PG |
|---|---|---|---|
| Operating cash flow / net income | 1.31 | 1.08 | 1.27
18th
|
| FCF / net income | 1.17 | 1.04 | 0.99
27th
|
| FCF / operating cash flow | 89.2% | 96.1% | 78.3%
56th
|
| Capex / operating cash flow | 10.8% | 3.9% | 21.7%
44th
|
| Accruals ratio | -5.0% | -2.0% | -3.4%
79th
|
| Sloan accruals ratio | 3.2% | -1.2% | -4.0%
42nd
|
| Earnings quality score (0-1) | 1.00 | 1.00 | 1.00
73rd
|
Scores & forensic checks
15 measures| Measure | PM | MO | PG |
|---|---|---|---|
| IS score | 77 | 65 | 64
89th
|
| IS profitability | 76 | 80 | 70
95th
|
| IS growth | 75 | 50 | 44
37th
|
| IS value | 45 | 53 | 48
53rd
|
| IS momentum | 90 | 64 | 72
63rd
|
| IS risk (safety) | 100 | 100 | 100
84th
|
| IS quality | 78 | 74 | 79
89th
|
| IS balance sheet | 43 | 38 | 63
89th
|
| IS earnings quality | 75 | 90 | 86
100th
|
| IS cash flow | 82 | 71 | 67
63rd
|
| Piotroski F-score (0-9) | 8 | 7 | 6
53rd
|
| Altman Z-score | 4.4 | 5.2 | 5.6
89th
|
| Beneish M-score | −2.64 | −2.33 | −2.67
79th
|
| Ohlson O-score | −7.29 | −7.02 | −8.85
11th
|
| IS credit score | 20 | 74 | 86
95th
|
Size (TTM)
8 measures| Measure | PM | MO | PG |
|---|---|---|---|
| Market cap | $319.8B | $125.4B | $370.0B
100th
|
| Revenue | $42.5B | $21.9B | $87.0B
100th
|
| EBITDA | $18.7B | $11.7B | $24.4B
100th
|
| Net income | $10.9B | $8.0B | $16.0B
100th
|
| Free cash flow | $12.7B | $8.3B | $15.9B
100th
|
| Total assets | $68.3B | $33.4B | $126.5B
100th
|
| Shareholders' equity | −$8.6B | −$2.7B | $54.3B
100th
|
| Employees | 84,900 | 5,900 | 104,000
100th
|
Price performance
9 measures| Measure | PM | MO | PG |
|---|---|---|---|
| 1 day | +2.5% | +1.7% | +1.4% |
| 1 week | +1.9% | +4.8% | +5.4% |
| 1 month | +8.5% | +7.8% | +8.0% |
| 3 months | +6.3% | +0.6% | +7.7% |
| 6 months | +29.9% | +17.1% | +10.1% |
| Year to date | +27.8% | +31.1% | +14.9% |
| 1 year | +29.9% | +15.8% | +11.3% |
| 3 years, cumulative | +140.3% | +106.5% | +20.6% |
| 5 years, cumulative | +161.2% | +121.0% | +27.8% |
Technicals
4 measures| Measure | PM | MO | PG |
|---|---|---|---|
| RSI 14 | 64.0 | 76.8 | 75.2 |
| From 52-week high | −2.6% | −2.5% | −3.3% |
| From 52-week low | +44.2% | +37.3% | +18.4% |
| Beta | 0.36 | 0.46 | 0.38 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17